Niacin lowers risk of stroke by an average of 26%

Posted by .(JavaScript must be enabled to view this email address)
Thursday, March 05, 2020 6:40 am Email this article

Niacin lowers the risk of a stroke by an average of 26% according to a meta-analysis of eleven (11) studies which involved a total of 6545 people.

 

Reference

Bruckert E, Labreuche J, and Amarenco P. Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis, 2010 Jun; 210(2): 353-361.

Author’s Contact Info

Eric Bruckert
Department of Endocrinology
Pitie-Salpetriere University Hospital
Pierre and Marie Curie University
83 bd de l’hopital
75651, Paris, France
.(JavaScript must be enabled to view this email address)

Other articles about niacin

Niacin lowers risk of heart attack or dying from a heart attack by an average of 25%

Niacin lowers risk of stroke by an average of 26%

Niacin raises HDL by an average of 20%

Niacin lowers LDL by an average of 16%

Niacin lowers triglycerides by an average of 20%

Niacin lowers Lp(a) by an average of 28%

Niacin lowers C-reactive protein by an average of 24%

Niacin use associated with a 25% reduction in heart attack or cardiac death

Niacin use associated with a 34% reduction in cardiovascular events

3 grams of niacin reduced stroke risk by 24% during 6.5 year follow-up

3 grams of niacin reduced heart attack risk by 26% during 6.5 year follow-up

3 grams of niacin reduced coronary revascularization risk by 67% during 6.5 year follow-up

3 grams of niacin reduced total mortality by 11% at a 15 year follow-up

Niacin may increase lifespan, Abram Hoffer, MD and Linus Pauling, PhD live to 92 and 93

Paradoxically the more Zetia (ezetimibe) lowered LDL, the greater the progression of atherosclerosis

Dose of extended-release niacin, 2000 mg in 75%, 1500 mg in 3%, 1000 mg in 12%, 500 mg in 10%

Niacin reduced total deaths by 86% compared to Zetia (ezetimibe) in statin users (1 vs 7 deaths)

Niacin reduced heart attacks by 67% versus Zetia (ezetimibe) in statin users (1 vs 3 heart attacks)

Niacin eliminated heart bypasses by 100% versus Zetia (ezetimibe) in statin users (0 vs 3 bypasses)

Niacin reduced cardiovascular deaths 80% versus Zetia (ezetimibe) in statin users (1 vs 5 deaths)

Articles on the same subject can be found here:

• Cholesterol

• Cholesterol drugs

• Niacin (vitamin B3)

• Stroke, ischemic

• Triglyceride levels